Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone

Psychiatry Research - Neuroimaging

Volumn 68, Issue 1, 1996, Pages 23-30

  Küfferle, Bernd ^a   Brücke, Thomas ^a   Topitz Schratzberger, Andrea ^a   Tauscher, Johannes ^a   Gössler, Ralf ^a   Vesely, Christine ^a   Asenbaum, Susanne ^a   Podreka, Ivo ^a   Kasper, Siegfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

basal ganglia; haloperidol; schizophrenia; single photon emission computed tomography

Indexed keywords

DOPAMINE 2 RECEPTOR; HALOPERIDOL; RISPERIDONE;

ADULT; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FRONTAL LOBE; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BENZAMIDES; BRAIN MAPPING; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; PYRROLIDINES; RECEPTORS, DOPAMINE D2; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030602091     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(96)02839-9     Document Type: Article

References (25)

1. American Psychiatric Association. (1994) DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th edn. American Psychiatric Press, Washington, DC.
2. Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie (1981) Das AMDP-System. Springer, Berlin-Heidelberg-New York.
3. Barnes, T.R.E. (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154, 672-676.
4. 2 antagonist ritanserin in neuroleptic-induced parkinsonism: A double-blind comparison with adrine and placebo. Clin Neuropharmacol 13, 500-506.
5. 2-Rezeptoren mittels J-IBZM-SPECT bei schizophrenen Patienten. In: Baumann, P (Ed.), Biologische Psychiatrie der Gegenwart. Springer, Vienna-New York, pp. 511-513.
6. 2 receptor imaging with SPECT: Studies in different neuropsychiatric disorders. J Cereb Blood Flow Metab 11, 220-228.
7. Brücke, T., Podreka, L., Wenger, S., Angelberger, P., Müller, C., Walter, H., Strobl, R. and Deecke, L. (1991b) Dopamine receptor imaging with SPECT: A tool in extrapyramidal disorders and in vivo assay for the measurement of receptor blockade by neuroleptic treatment. (Abstract) J Cereb Blood Flow Metab 11(S2), 877.
8. 2-receptor blockade by typical and atypical neuroleptics. Lancet 339, 497.
9. 123I-IBZM single photon emission tomography (SPET) study. Psychopharmacology 117, 55-61.
10. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Arch Gen Psychiatry 49, 538-544.
11. 2 dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology 99, 28-31.
12. Grünwald, F., Danos, P., Kasper, S., Reichmann, K., Briele B., Klemm, E., Rieker, O., Shih, W.J., Möller, H.J. and Biersack, H.J. (1993) IBZM SPECT in psychiatric diseases. In: Radioactive Isotopes in Clinical Medicine and Research. Schattauer, Stuttgart-New York.
13. 2 receptor blockade after depot neuroleptics. J Neural Transm 94, 217-221.
14. Hicks, P.B. (1990) The effect of serotonergic agents on haloperidol-induced catalepsy. Life Sci 47, 1609-1615.
15. 2 antagonistic properties. J Pharmacol Exp Ther 244, 685-693.
16. Kay, S.R., Fiszbein, A. and Opler, L.A. (1987) The Positive and Negative Symptome Scale (PANSS) for Schizophrenia. Schizophr Bull 13, 261-276.
17. 2 receptor occupancy in vivo and response to the new antipsychotic risperidone. Br J Psychiatry 163, 833-834.
18. McEvoy, J.P. (1994) Efficacy of risperidone on positive features of schizophrenia. J Clin Psychiatry 55 (Suppl. 5), 18-21.
19. 2 dopamine receptor occupancy in the living human brain. Psychopharmacology 110, 265-272.
20. Owens, D.G.C. (1994) Extrapyramidal side effects and tolerability of risperidone: A review. J Clin Psychiatry 55 (Suppl. 5), 29-35.
21. 2-dopamine receptor occupancy during treatment with typical and atypical neuroleptics. Biol Psychiatry 36, 627-629.
22. Schooler, N. (1994) Negative symptoms in schizophrenia: Assessment of the effect of risperidone. J Clin Psychiatry 55 (Suppl. 5), 22-28.
23. 2 receptors in human subjects with iodine 123-IBZM. J Nucl Med 33, 1964-1971.
24. Simpson, G.M. and Angus, J.W.S. (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212, 11-19.
25. Wojcik J.D., Gelenberg A.J., Labrie R.A. and Mieske, M. (1980) Prevalence of tardive dyskinesia in an outpatient population. Compr Psychiatry 21, 370-380.